Q-linea’s ASTar – a success on ECCMID

Q-linea AB (publ) (OMX: QLINEA), a diagnostic company focused on developing and delivering solutions to accurately and rapidly diagnose infectious diseases, now presents the final design of ASTar for potential customers at the most important trade fair; the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), this year being held in Amsterdam, 13-16 April.

Q-linea AB acquires Umbrella Science

UPPSALA, Sweden, June 30th, 2018 - Q-linea AB, a diagnostic company focused on developing and delivering solutions to accurately and rapidly diagnose infectious diseases, announced that the company has acquired Umbrella Science AB in an asset deal. The total purchase price is SEK 12.8 million.